{"id":"a3a5b13e-db0a-4188-8d3f-68bed7b12722","modelId":"4e82b737-eeed-40fa-96b8-c426df7e5c52","versionId":null,"locationId":"828f9784-5535-4787-a6ea-4e2d27c3926f","operatorId":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","ownerId":null,"slug":"motif-bci-united-states-usa","status":"operational","firstSeen":"2024-06-01T00:00:00.000Z","statusChangeReason":null,"contractType":null,"pilotOutcome":null,"endedAt":null,"unitsOnSite":null,"tasksPerformed":["identity_verification","access_control","security_screening"],"shiftStructure":null,"hoursPerDay":24,"siteType":"commercial","operatorConfirmed":null,"humanSupervisionOnsite":null,"locationPrecisionTier":"city_centroid","deploymentScale":"medium_11_100","siteEnvironment":"indoor","operatorType":"customer_deployed","sourceQualityTier":8,"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[],"notes":"Commercial product — available for purchase in this market.","keyFacts":[],"reviewNote":"Bulk deepened — form-factor-based metadata assignment","exposureHours":null,"deploymentMilesEstimate":null,"exposureBasis":null,"customerSegment":"retail","scaleTier":"commercial_10_99","contractValueUsd":null,"contractValueBasis":null,"customerCompanyId":null,"customerExternalName":null,"createdAt":"2026-08-20T04:09:15.144Z","updatedAt":"2026-08-20T16:27:55.889Z","model":{"id":"4e82b737-eeed-40fa-96b8-c426df7e5c52","companyId":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","modelName":"Motif BCI","slug":"motif-bci","description":"Wirelessly powered implantable BCI delivering targeted brain stimulation for treatment-resistant depression.","formFactor":"biometric","industryVertical":"healthcare","environment":"indoor","maturityStage":"pilot","lifecycleState":"active","supersededByModelId":null,"specs":{},"manufacturerSerial":null,"reviewStatus":"reviewed","sources":[{"url":"https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial","title":"Brain-computer interface based on Rice research wins FDA approval for first clinical trial","sourceName":"Rice University News"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"manufacturerTermForTeleop":null,"keyFacts":[{"label":"Form Factor","value":"biometric"},{"label":"Maturity","value":"pilot"}],"createdAt":"2026-08-08T22:32:35.975Z","updatedAt":"2026-08-09T03:57:34.330Z","unitsInFieldClaimed":null,"unitsInFieldVerified":null,"unitsManufacturedClaimed":null,"unitsManufacturedVerified":null,"unitsAsOf":null,"unitsSource":null,"salesModel":null,"priceUndisclosedSince":null,"autonomyClass":null,"autonomyStatement":null,"autonomyStatementSource":null,"demoForensics":null,"exportControlClass":null,"minCommitment":null,"warrantyTerms":null,"serviceModel":null,"productionRateClaimed":null,"productionRateEvidenced":null,"teleopRatioDisclosed":null,"interventionRateDisclosed":null,"company":{"id":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","name":"Motif Neurotech","slug":"motif-neurotech","description":"Motif Neurotech is a Houston-based brain-computer interface company developing an implantable therapeutic BCI for treatment-resistant depression. Its [Motif BCI](/models/motif-bci) XCS System is a wirelessly-powered implant delivering electrical stimulation to brain circuits linked to depression. FDA approved its first clinical trial (RESONATE) in April 2026, making Motif the fastest implantable BCI company from founding to IDE approval.","status":"private","founded":2022,"hq":"Houston, Texas, USA","hqLat":29.7589382,"hqLng":-95.3676974,"hqGeocodedAt":"2026-08-23T21:16:59.827Z","hqAddress":null,"hqPrecision":null,"website":"motifneuro.tech","fundingTotal":"18750000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial","title":"Brain-computer interface based on Rice research wins FDA approval for first clinical trial","sourceName":"Rice University News"}],"keyFacts":[{"label":"FDA","value":"IDE approved April 2026"},{"label":"Indication","value":"Treatment-resistant depression"},{"label":"Program","value":"ARPA-H behavioral health"},{"label":"Origin","value":"Rice University research"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:35.528Z","updatedAt":"2026-08-21T22:31:16.597Z"}},"version":null,"location":{"id":"828f9784-5535-4787-a6ea-4e2d27c3926f","name":"United States (multiple hotel chains)","slug":"united-states-usa","kind":"facility","parentLocationId":null,"region":"United States","lat":null,"lng":null,"reviewStatus":"reviewed","aliases":[],"collisionRisk":"high","reviewNote":null,"createdAt":"2026-08-12T22:57:01.647Z","updatedAt":"2026-08-14T16:09:25.839Z"},"operator":{"id":"0cd83b28-d0e9-4f17-be61-c9d20d2b618f","name":"Motif Neurotech","slug":"motif-neurotech","description":"Motif Neurotech is a Houston-based brain-computer interface company developing an implantable therapeutic BCI for treatment-resistant depression. Its [Motif BCI](/models/motif-bci) XCS System is a wirelessly-powered implant delivering electrical stimulation to brain circuits linked to depression. FDA approved its first clinical trial (RESONATE) in April 2026, making Motif the fastest implantable BCI company from founding to IDE approval.","status":"private","founded":2022,"hq":"Houston, Texas, USA","hqLat":29.7589382,"hqLng":-95.3676974,"hqGeocodedAt":"2026-08-23T21:16:59.827Z","hqAddress":null,"hqPrecision":null,"website":"motifneuro.tech","fundingTotal":"18750000","type":"hardware","roles":["robot_maker","robot_operator"],"reviewStatus":"reviewed","lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial","title":"Brain-computer interface based on Rice research wins FDA approval for first clinical trial","sourceName":"Rice University News"}],"keyFacts":[{"label":"FDA","value":"IDE approved April 2026"},{"label":"Indication","value":"Treatment-resistant depression"},{"label":"Program","value":"ARPA-H behavioral health"},{"label":"Origin","value":"Rice University research"}],"aliases":[],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-08-08T22:32:35.528Z","updatedAt":"2026-08-21T22:31:16.597Z"},"owner":null,"derived":{"trustTier":"unverified","currentPosture":null},"jsonLd":{"@context":"https://schema.org","@type":"Event","@id":"https://registry.deploy.report/deployments/motif-bci-united-states-usa","url":"https://registry.deploy.report/deployments/motif-bci-united-states-usa","name":"Motif BCI at United States (multiple hotel chains)","identifier":"a3a5b13e-db0a-4188-8d3f-68bed7b12722","startDate":"2024-06-01T00:00:00.000Z","location":{"@type":"Place","@id":"https://registry.deploy.report/locations/united-states-usa","name":"United States (multiple hotel chains)"},"organizer":{"@type":"Organization","@id":"https://registry.deploy.report/companies/motif-neurotech","name":"Motif Neurotech"},"about":{"@type":"Product","@id":"https://registry.deploy.report/models/motif-bci","name":"Motif BCI"},"publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"claimed-not-verified","maturity_stage":"pilot","lifecycle_state":"active","architectural_position":{"cohort":"biometric","sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":0,"primary_source_types":[]}}}